Fatty liver
Showing 1 - 25 of >10,000
Non-Alcoholic Fatty Liver Disease Trial (Standard Soy Milk, 2% Fat Cow's Milk)
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Standard Soy Milk
- 2% Fat Cow's Milk
- (no location specified)
Nov 9, 2023
Effect of Thyroid Disorders in Liver Diseases
Not yet recruiting
- Fatty Liver Disease
- Fibroscan
- (no location specified)
Oct 6, 2023
Non-Alcoholic Fatty Liver Disease Trial in Zagazig (abdominal U/S, Fibroscan with Controlled Attenuated Parameter (CAP scan):)
Enrolling by invitation
- Non-Alcoholic Fatty Liver Disease
- abdominal U/S
- Fibroscan with Controlled Attenuated Parameter (CAP scan):
-
Zagazig, Sharkia, EgyptZagazig University
Oct 24, 2023
Vitamin A and Calcium in Non-alcoholic Fatty Liver Disease
Completed
- Effect of Vitamin A and Calcium in Patients With Non-alcoholic Fatty Liver Patients
-
Sohag, EgyptSohag university Hospital
Sep 4, 2023
Non-Alcoholic Fatty Liver Disease (NAFLD) Trial in Jakarta Pusat (Proliverenol, Placebo caplets of Proliverenol)
Recruiting
- Non-Alcoholic Fatty Liver Disease (NAFLD)
- Proliverenol
- Placebo caplets of Proliverenol
-
Jakarta Pusat, Jakarta, IndonesiaDivision of Hepatology, Dr. Cipto Mangunkusumo Hospital
Nov 7, 2023
HIV, Non-Alcoholic Fatty Liver Disease, Metabolic-Associated Steatotic Liver Disease Trial in Nashville (Prebiotic, Probiotic)
Not yet recruiting
- HIV
- +2 more
- Prebiotic
- Probiotic
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 30, 2023
Non-Alcoholic Fatty Liver Disease Trial in Seoul (GODEX, Placebo)
Enrolling by invitation
- Non-Alcoholic Fatty Liver Disease
- GODEX
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 30, 2023
Non-alcoholic Fatty Liver Disease in Low Birth Weight
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Low Birth Weight
- (no location specified)
Jun 6, 2023
Type 2 Diabetes, Non Alcholic Fatty Liver Disease Trial (Bempedoic acid)
Not yet recruiting
- Type 2 Diabetes
- Non Alcholic Fatty Liver Disease
- Bempedoic acid
- (no location specified)
Sep 14, 2023
Non-Alcoholic Fatty Liver Disease Trial in Rio de Janeiro
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
-
Rio de Janeiro, RJ, BrazilFederal University of Rio de Janeiro
Jun 7, 2023
Non-Alcoholic Fatty Liver Disease, Liver Fat, Obesity Trial in Dublin (Standard healthy eating advice, eTRE plus Mediterranean
Recruiting
- Non-Alcoholic Fatty Liver Disease
- +3 more
- Standard healthy eating advice
- eTRE plus Mediterranean diet
-
Dublin, Leinster, IrelandUniversity College Dublin
Jul 26, 2023
Transient Elastograghy to Detect Non Alcoholic Fatty Liver
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Renal Transplant Complication Pre-Existing Disease
- transient elastograghy
- (no location specified)
May 30, 2023
Defining Circadian Metabolism in Non-alcoholic Fatty Liver
Recruiting
- NAFLD
- Lifestyle and weight loss advice
-
Oxford, United KingdomUniversity of Oxford
Jul 18, 2023
Fatty Liver Disease, Fatty Liver Trial in Giza (Itopride, conventional therapy)
Recruiting
- Fatty Liver Disease
- Fatty Liver
- Itopride
- conventional therapy
-
Giza, EgyptMaha Youssif Fekry
Jul 28, 2023
Non-Alcoholic Fatty Liver Disease Trial (Field-cycling imaging (FCI))
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Field-cycling imaging (FCI)
- (no location specified)
Apr 21, 2023
Non-alcoholic Fatty Liver Disease Trial in Taichung (Jing-Si Herbal Tea, Placebo Jing-Si Herbal Tea)
Recruiting
- Non-alcoholic Fatty Liver Disease
- Jing-Si Herbal Tea
- Placebo Jing-Si Herbal Tea
-
Taichung, TaiwanTaichung Tzu Chi Hospital
May 12, 2023
Liver Fat Content and Bariatric Surgery
Recruiting
- Non-Alcoholic Fatty Liver Disease
- +2 more
- We do not have any intervention type
-
Qingdao, Shandong, ChinaQingdao University Affiliated Hospital
Sep 29, 2023
Type1diabetes, Fatty Liver Trial in Afula (liver elastography)
Enrolling by invitation
- Type1diabetes
- Fatty Liver
- liver elastography
-
Afula, Israel/zaphon, IsraelEmek Medical Center
Jul 3, 2023
Metabolic Associated Fatty Liver Disease Trial in Mexico (LUDLEV®300 mg/46.2 mg, Placebo)
Recruiting
- Metabolic Associated Fatty Liver Disease
- LUDLEV®300 mg/46.2 mg
- Placebo
-
Mexico, Veracruz, MexicoAna Delfina Cano Contreras
Jun 12, 2023
Subclinical Cardiac Dysfunction in Non-Alcoholic Fatty Liver
Not yet recruiting
- NAFLD
- Echocardiographic findings
- (no location specified)
Nov 11, 2023
NAFLD Trial in Ahvaz (Soy isoflavone, Placebo)
Completed
- NAFLD
- Soy isoflavone
- Placebo
-
Ahvaz, Khuzestan, Iran, Islamic Republic ofAsal Neshatbini Tehrani
Oct 24, 2023
Non-Alcoholic Fatty Liver Disease Trial in Hong Kong (SIM01)
Recruiting
- Non-Alcoholic Fatty Liver Disease
- SIM01
-
Hong Kong, Hong KongGenieBiome Limited
May 22, 2023
Non-Alcoholic Fatty Liver Disease Trial (Calisthenics exercise)
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Calisthenics exercise
- (no location specified)
Sep 9, 2023
Betweenq MAFLD and Chronic Kidney Disease
Not yet recruiting
- Mafld in Ckd Patients
- (no location specified)
Nov 12, 2023
Non-alcoholic Fatty Liver Disease in Chronic Kidney Disease in
Not yet recruiting
- CKD
- NAFLD
- (no location specified)
Aug 22, 2023